AHR exec logs tax-withholding share disposition

American Healthcare REIT, Inc. executive Mark E. Foster reported a tax-related share disposition.

Accepted by SEC EDGAR 02/11/2026 - 04:24 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

American Healthcare REIT, Inc. executive Mark E. Foster reported a tax-related share disposition. On February 9, 2026, the company repurchased 7,685 shares of common stock at $48.77 per share from Foster to cover his tax obligations from vesting restricted stock. Following this tax-withholding transaction, Foster directly beneficially owns 49,915 shares of American Healthcare REIT common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 7,685 shares

Exercise Price or Tax Liability 1 txn

Insider Foster Mark E.

Role EVP, GC & Secretary

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	7,685	$48.77	$375K

Holdings After Transaction: Common Stock — 49,915 shares (Direct)

Holdings Before and After: Common Stock, 57,600 to 49,915 shares (Direct)

Footnotes (1)

1. F1. Represents shares repurchased by the Issuer on February 9, 2026 to satisfy the Reporting Person's tax obligations associated with the vesting of shares of restricted common stock on February 9, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AHR executive Mark E. Foster report?

Mark E. Foster reported a tax-withholding disposition of American Healthcare REIT, Inc. common stock. On February 9, 2026, the issuer repurchased 7,685 shares to satisfy his tax obligations from restricted stock vesting at a price of $48.77 per share.

Was Mark E. Foster’s AHR Form 4 transaction an open-market sale?

The transaction was not an open-market sale. It was a tax-withholding disposition, where American Healthcare REIT, Inc. repurchased 7,685 shares from Mark E. Foster to cover taxes due on vesting restricted common stock.

How many AHR shares does Mark E. Foster own after this transaction?

After the reported transaction, Mark E. Foster directly beneficially owns 49,915 shares of American Healthcare REIT, Inc. common stock. This figure reflects his holdings following the 7,685-share tax-withholding repurchase on February 9, 2026.

What price per share was used for the AHR tax-withholding transaction?

The tax-withholding disposition used a price of $48.77 per share. American Healthcare REIT, Inc. repurchased 7,685 shares from Mark E. Foster at this price to satisfy his tax obligations tied to restricted stock vesting.

What is Mark E. Foster’s role at American Healthcare REIT, Inc.?

Mark E. Foster serves as Executive Vice President, General Counsel and Secretary of American Healthcare REIT, Inc. His Form 4 filing reflects a routine tax-withholding share repurchase related to equity compensation vesting on February 9, 2026.

What does transaction code F mean in the AHR Form 4 filing?

Transaction code F in the Form 4 indicates a disposition of shares to pay an exercise price or tax liability. In this case, American Healthcare REIT, Inc. repurchased 7,685 shares from Mark E. Foster to cover taxes from restricted stock vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foster Mark E.

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE CA 92612

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		F		7,685(1)	D	$48.77	49,915	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares repurchased by the Issuer on February 9, 2026 to satisfy the Reporting Person's tax obligations associated with the vesting of shares of restricted common stock on February 9, 2026.

	/s/ MARK E. FOSTER	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.